1Abraham WT, Lowes BD, Ferguson DA, et al. Systemic hemodynamic,neurohormonal, and renal effects of a steady - state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure[J]. J Card Fail, 1998,4 : 37 - 44.
2Tsutamoto T, Wada A, Maeda K, et al. Plasma brain natriuretic peptide levels as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction[J]. Eur Heart J, 1999,20 : 1799 - 1807.
3Collucci WS. The effects of norepinephrine on myocardial biology: Implication for the therapy of heart failure[J], Clin Cariol, 21:120 - 124.
4Communal C , Singh K , Pimentel DR , et al . Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β - adrenergic pathway[J]. Circulation, 1998,98 : 1329.
6Unger T. Neurohormonal modulation in cardiovascular disease [J]. Am Heart J,2000,139:2 -8.
7Dostal DE,Baker KM. Angiotensin Ⅱ stimulation of left ventricular hypertrophy in adult rat heart mediatin by the AT1 receptor [J]. Am J Hypertens,1992,5 :276 - 280.
8Urata H ,Hoffmann S,Ganten D. Tissue angiotensin Ⅱ system in the human heart[J]. Eur Heart J, 1994,15 : 68 - 78.
9Brand T,Schneider MD. The TGF beta supefamily in myocardium: Ligands,receptor,transduction,and function[J] J Mol Cell Cardiol, 1997,27:5 - 18.
10Weber KT,Brilla CG. Pathological hypertrophy and cardiac intersitium:Fibrosis and renin - angiotensin - aldosterone system [J]. Circulation, 1991,8; : 1849 - 1865.
